[ad_1]
“Lithuania trusts the experts: the European Medicines Agency and the State Medicines Control Agency. They say that there is currently no evidence that the vaccine is harmful. We are monitoring the situation, but we do not intend to stop the vaccination process. with this vaccine, only one specific shipment has been stopped, ”said Health Minister spokeswoman Aistė Šuksta.
At the beginning of the week, Lithuania stopped vaccination with a single batch of the AstraZeneca vaccine, raising suspicions about blood clots.
AstraZeneca Announces Vaccine Closure One After Another
Denmark announced on Thursday that it would suspend vaccination with AstraZeneca against the coronavirus vaccine for two weeks due to blood clots in some patients.
However, the country’s officials noted that this decision is preventive, since at present a causal link between the vaccine and the clots has not been established. Subsequently, Norway and Iceland made a similar decision.
Italy, for its part, has announced the temporary suspension of a shipment of AstraZeneca vaccines, but not the same as Austria, Lithuania and several other European Union countries.
The Lithuanian Ministry of Health announced on Tuesday that it had suspended a series of vaccines against AstraZeneca after receiving information from the Austrian authorities about dangerous side effects.
Austria itself discontinued vaccination with the ABV5300 series of AstraZeneca vaccines this week after a 49-year-old woman died of a blood clotting disorder and another 35-year-old woman developed a pulmonary embolism. These reactions are investigated to elucidate the causal relationship.
The European Medicines Agency (EMA), for its part, says a preliminary investigation has shown that AstraZeneca’s batch of vaccines cannot be blamed for the woman’s death.
Also, the EVA says that vaccinated people are unlikely to have an increased risk of blood clots.
Currently, three COVID-19 vaccines approved by the European Medicines Agency are used in Lithuania: Pfizer and BioNTech, Moderna and AstraZeneca.
